CHIKUNGUNYA VIRUS INFECTION
Clinical trials for CHIKUNGUNYA VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA VIRUS INFECTION trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chikungunya vaccine enters first human safety trial
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new vaccine called PepGNP-ChikV, designed to protect against chikungunya virus. About 40 healthy adults aged 18-60 will receive two shots, 42 days apart, and be monitored for safety and immune response for a year. The study aims to see if the vaccin…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 10:12 UTC
-
New study to check chikungunya vaccine safety in pregnant women
Knowledge-focused Not yet recruitingThis study looks at the safety of a chikungunya vaccine (VLA1553) in pregnant women in Brazil. Researchers will track the health of 200 women who got the vaccine during pregnancy or just before, and their babies up to 12 weeks after birth. They will compare these results with a s…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Sponsor: Valneva Austria GmbH • Aim: Knowledge-focused
Last updated May 26, 2026 10:09 UTC